がん生物学の世界市場2019-2023...市場調査レポートについてご紹介

【英文タイトル】Global Cancer Biologics Market 2019-2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Monoclonal antibodies – Market size and forecast 2018-2023

Vaccines – Market size and forecast 2018-2023

Cell and gene therapy – Market size and forecast 2018-2023

Others – Market size and forecast 2018-2023

Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Amgen Inc.

Bristol-Myers Squibb Company

Eli Lilly and Company

F. Hoffmann-La Roche Ltd

Merck & Co., Inc.

PART 14: APPENDIX

Research methodology

List of abbreviations

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global oncology therapeutics market

Exhibit 02: Segments of global oncology therapeutics market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Product – Market share 2018-2023 (%)

Exhibit 18: Comparison by product

Exhibit 19: Monoclonal antibodies – Market size and forecast 2018-2023 ($ millions)

Exhibit 20: Monoclonal antibodies – Year-over-year growth 2019-2023 (%)

Exhibit 21: Vaccines – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Vaccines – Year-over-year growth 2019-2023 (%)

Exhibit 23: Cell and gene therapy – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Cell and gene therapy – Year-over-year growth 2019-2023 (%)

Exhibit 25: Others – Market size and forecast 2018-2023 ($ millions)

Exhibit 26: Others – Year-over-year growth 2019-2023 (%)

Exhibit 27: Market opportunity by product

Exhibit 28: Customer landscape

Exhibit 29: Market share by geography 2018-2023 (%)

Exhibit 30: Geographic comparison

Exhibit 31: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 32: North America – Year-over-year growth 2019-2023 (%)

Exhibit 33: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 35: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 37: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 38: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 39: Key leading countries

Exhibit 40: Market opportunity

Exhibit 41: Biologics in the pipeline for cancer

Exhibit 42: List of recently approved cancer biologics by the FDA

Exhibit 43: Cancer biologics and their biosimilar versions

Exhibit 44: Impact of drivers and challenges

Exhibit 45: List of collaborations between manufacturers of cancer biologics

Exhibit 46: List of predictive biomarkers for cancer

Exhibit 47: Vendor landscape

Exhibit 48: Landscape disruption

Exhibit 49: Vendors covered

Exhibit 50: Vendor classification

Exhibit 51: Market positioning of vendors

Exhibit 52: Amgen Inc. – Vendor overview

Exhibit 53: Amgen Inc. – Business segments

Exhibit 54: Amgen Inc. – Organizational developments

Exhibit 55: Amgen Inc. – Geographic focus

Exhibit 56: Amgen Inc. – Key offerings

Exhibit 57: Bristol-Myers Squibb Company – Vendor overview

Exhibit 58: Bristol-Myers Squibb Company – Business segments

Exhibit 59: Bristol-Myers Squibb Company – Organizational developments

Exhibit 60: Bristol-Myers Squibb Company – Geographic focus

Exhibit 61: Bristol-Myers Squibb Company – Key offerings

Exhibit 62: Eli Lilly and Company – Vendor overview

Exhibit 63: Eli Lilly and Company – Business segments

Exhibit 64: Eli Lilly and Company – Organizational developments

Exhibit 65: Eli Lilly and Company – Geographic focus

Exhibit 66: Eli Lilly and Company – Segment focus

Exhibit 67: Eli Lilly and Company – Key offerings

Exhibit 68: F. Hoffmann-La Roche Ltd – Vendor overview

Exhibit 69: F. Hoffmann-La Roche Ltd – Business segments

Exhibit 70: F. Hoffmann-La Roche Ltd – Organizational developments

Exhibit 71: F. Hoffmann-La Roche Ltd – Geographic focus

Exhibit 72: F. Hoffmann-La Roche Ltd – Segment focus

Exhibit 73: F. Hoffmann-La Roche Ltd – Key offerings

Exhibit 74: Merck & Co., Inc. – Vendor overview

Exhibit 75: Merck & Co., Inc. – Business segments

Exhibit 76: Merck & Co., Inc. – Organizational developments

Exhibit 77: Merck & Co., Inc. – Geographic focus

Exhibit 78: Merck & Co., Inc. – Segment focus

Exhibit 79: Merck & Co., Inc. – Key offerings

Exhibit 80: Validation techniques employed for market sizing


【レポート販売概要】

■ タイトル:がん生物学の世界市場2019-2023
■ 英文:Global Cancer Biologics Market 2019-2023
■ 発行日:2019年4月17日
■ 調査会社:Technavio
■ 商品コード:IRTNTR31171
■ 調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。